Vanguard reports 5.23% stake in Enovis (ENOV)
Rhea-AI Filing Summary
Enovis Corp reported a Schedule 13G ownership disclosure by Vanguard Capital Management. Vanguard reports 2,995,321 shares beneficially owned, representing 5.23% of Enovis common stock. The filing shows sole dispositive power over 2,995,321 shares and sole voting power for 442,970 shares. The report is signed by Vanguard's Head of Global Fund Administration.
Positive
- None.
Negative
- None.
Key Figures
Shares beneficially owned: 2,995,321 shares
Percent of class: 5.23%
Sole voting power: 442,970 shares
+3 more
6 metrics
Shares beneficially owned
2,995,321 shares
Amount beneficially owned reported on Schedule 13G
Percent of class
5.23%
Percent of Enovis common stock reported
Sole voting power
442,970 shares
Number of shares with sole power to vote
Sole dispositive power
2,995,321 shares
Number of shares with sole power to dispose
CUSIP
194014502
CUSIP for Enovis common stock shown on the filing
Signature date
04/29/2026
Date the Schedule 13G was signed
Key Terms
Schedule 13G, beneficially owned, sole dispositive power, sole voting power
4 terms
Schedule 13G regulatory
"Item 1. | (a) | Name of issuer: Enovis Corp"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
beneficially owned financial
"Item 4. | Ownership (a) | Amount beneficially owned: 2995321"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
sole dispositive power regulatory
"(iii) Sole power to dispose or to direct the disposition of: 2995321"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
sole voting power regulatory
"(i) Sole power to vote or to direct the vote: 442970"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What stake does Vanguard Capital Management report in ENOV?
Vanguard reports owning 2,995,321 shares, or 5.23% of Enovis common stock. The filing lists voting and dispositive powers held by Vanguard entities as reported on the Schedule 13G.
How much voting power does Vanguard have in Enovis (ENOV)?
Vanguard reports sole voting power for 442,970 shares and no shared voting power. The Schedule 13G breaks out sole versus shared voting and dispositive authority.
Who filed the Schedule 13G for ENOV on behalf of Vanguard?
The filing was submitted by Vanguard Capital Management and signed by Ashley Grim. Ashley Grim is listed as Head of Global Fund Administration with the signature dated 04/29/2026.
What address is listed for Enovis Corp in the filing?
Enovis Corp's principal executive offices are listed at 2711 Centerville Rd, Suite 400, Wilmington, DE 19808. This address appears under the issuer information in the Schedule 13G.